Brief: Lavipharm Announces The Launch Of The First Locally Produced Cannabis-Based Prescription Medicine
Feb 23 (Reuters) - Lavipharm SA LPHr.AT :
* ANNOUNCES THE LAUNCH OF THE FIRST LOCALLY PRODUCED
CANNABIS-BASED PRESCRIPTION MEDICINE
* THE PHARMACEUTICAL PRODUCT IS LAUNCHED ON THE GREEK MARKET
AS A
RESULT OF LAVIPHARM'S STRATEGIC PARTNERSHIP WITH TIKUN OLAM AND
IS PRODUCED AT THE LATTER’S PLANT IN CORINTH
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY